Chronic respiratory disease disparity between American Indian/Alaska Native and white populations, 2011-2018.
American Indian/Alaskan Native
BRFSS
Chronic respiratory disease
Health disparities
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
28 07 2021
28 07 2021
Historique:
received:
03
11
2020
accepted:
21
07
2021
entrez:
29
7
2021
pubmed:
30
7
2021
medline:
6
8
2021
Statut:
epublish
Résumé
American Indian/Alaska Native (AI/AN) populations have been disproportionately affected by chronic respiratory diseases for reasons incompletely understood. Past research into disease disparity using population-based surveys mostly focused on state-specific factors. The present study investigates the independent contributions of AI/AN racial status and other socioeconomic/demographic variables to chronic respiratory disease disparity in an 11-state region with historically high AI/AN representation. Using data from the Behavioral Risk Factor Surveillance System (BRFSS) spanning years 2011-2018, this work provides an updated assessment of disease disparity and potential determinants of respiratory health in AI/AN populations. This cross-sectional study used data from the BRFSS survey, 2011-2018. The study population included AI/AN and non-Hispanic white individuals resident in 11 states with increased proportion of AI/AN individuals. The yearly number of respondents averaged 75,029 (62878-87,350) which included approximately 5% AI/AN respondents (4.5-6.3%). We compared the yearly adjusted prevalence for chronic respiratory disease, where disease status was defined by self-reported history of having asthma and/or chronic obstructive pulmonary disease (COPD). Multivariable logistic regression was performed to determine if being AI/AN was independently associated with chronic respiratory disease. Covariates included demographic (age, sex), socioeconomic (marital status, education level, annual household income), and behavioral (smoking, weight morbidity) variables. The AI/AN population consistently displayed higher adjusted prevalence of chronic respiratory disease compared to the non-Hispanic white population. However, the AI/AN race/ethnicity characteristic was not independently associated with chronic respiratory disease (OR, 0.93; 95% CI, 0.79-1.10 in 2017). In contrast, indicators of low socioeconomic status such as annual household income of <$10,000 (OR, 2.02; 95% CI, 1.64-2.49 in 2017) and having less than high school education (OR, 1.37; 95% CI, 1.16-1.63 in 2017) were positively associated with disease. These trends persisted for all years analyzed. This study highlighted that AI/AN socioeconomic burdens are key determinants of chronic respiratory disease, in addition to well-established risk factors such as smoking and weight morbidity. Disease disparity experienced by the AI/AN population is therefore likely a symptom of disproportionate socioeconomic challenges they face. Further promotion of public health and social service efforts may be able to improve AI/AN health and decrease this disease disparity.
Sections du résumé
BACKGROUND
American Indian/Alaska Native (AI/AN) populations have been disproportionately affected by chronic respiratory diseases for reasons incompletely understood. Past research into disease disparity using population-based surveys mostly focused on state-specific factors. The present study investigates the independent contributions of AI/AN racial status and other socioeconomic/demographic variables to chronic respiratory disease disparity in an 11-state region with historically high AI/AN representation. Using data from the Behavioral Risk Factor Surveillance System (BRFSS) spanning years 2011-2018, this work provides an updated assessment of disease disparity and potential determinants of respiratory health in AI/AN populations.
METHODS
This cross-sectional study used data from the BRFSS survey, 2011-2018. The study population included AI/AN and non-Hispanic white individuals resident in 11 states with increased proportion of AI/AN individuals. The yearly number of respondents averaged 75,029 (62878-87,350) which included approximately 5% AI/AN respondents (4.5-6.3%). We compared the yearly adjusted prevalence for chronic respiratory disease, where disease status was defined by self-reported history of having asthma and/or chronic obstructive pulmonary disease (COPD). Multivariable logistic regression was performed to determine if being AI/AN was independently associated with chronic respiratory disease. Covariates included demographic (age, sex), socioeconomic (marital status, education level, annual household income), and behavioral (smoking, weight morbidity) variables.
RESULTS
The AI/AN population consistently displayed higher adjusted prevalence of chronic respiratory disease compared to the non-Hispanic white population. However, the AI/AN race/ethnicity characteristic was not independently associated with chronic respiratory disease (OR, 0.93; 95% CI, 0.79-1.10 in 2017). In contrast, indicators of low socioeconomic status such as annual household income of <$10,000 (OR, 2.02; 95% CI, 1.64-2.49 in 2017) and having less than high school education (OR, 1.37; 95% CI, 1.16-1.63 in 2017) were positively associated with disease. These trends persisted for all years analyzed.
CONCLUSIONS
This study highlighted that AI/AN socioeconomic burdens are key determinants of chronic respiratory disease, in addition to well-established risk factors such as smoking and weight morbidity. Disease disparity experienced by the AI/AN population is therefore likely a symptom of disproportionate socioeconomic challenges they face. Further promotion of public health and social service efforts may be able to improve AI/AN health and decrease this disease disparity.
Identifiants
pubmed: 34320979
doi: 10.1186/s12889-021-11528-8
pii: 10.1186/s12889-021-11528-8
pmc: PMC8317382
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1466Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM103841
Pays : United States
Informations de copyright
© 2021. The Author(s).
Références
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
pubmed: 11316667
Allergy Asthma Proc. 2015 Jan-Feb;36(1):4-10
pubmed: 25562549
Ann Am Thorac Soc. 2018 Mar;15(3):348-356
pubmed: 29323930
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):820-2
pubmed: 17416777
Ethn Health. 2009 Oct;14(5):527-52
pubmed: 19533477
Am J Prev Med. 2017 Jan;52(1S1):S5-S12
pubmed: 27989293
Med Care. 2010 Dec;48(12):1128-32
pubmed: 20940652
Ann Am Thorac Soc. 2018 Jun;15(6):745-753
pubmed: 29485894
Vaccine. 2020 Mar 4;38(11):2435-2448
pubmed: 31974017
J Environ Health. 2012 May;74(9):22-8
pubmed: 22590848
Am J Public Health. 2004 Jun;94(6):1037-42
pubmed: 15249312
Can Respir J. 2012 Nov-Dec;19(6):355-60
pubmed: 23248798
Ann N Y Acad Sci. 2008;1136:126-36
pubmed: 18579879
Int J Tuberc Lung Dis. 2009 Aug;13(8):1008-14
pubmed: 19723382
Respirology. 2017 Nov;22(8):1518-1528
pubmed: 28758310
Int J Chron Obstruct Pulmon Dis. 2016 Oct 04;11:2475-2496
pubmed: 27785005
N Engl J Med. 2014 Feb 13;370(7):640-9
pubmed: 24521110
Int J Environ Res Public Health. 2009 Jan;6(1):209-24
pubmed: 19440278
Chest. 2013 Jul;144(1):284-305
pubmed: 23619732
Curr Opin Allergy Clin Immunol. 2009 Apr;9(2):154-60
pubmed: 19326508
CA Cancer J Clin. 2018 Mar;68(2):106-115
pubmed: 29384589
Am J Public Health. 2013 Feb;103(2):e31-8
pubmed: 23237178
Chest. 2012 Nov;142(5):1308-1315
pubmed: 23131939
Eur Respir J. 2013 Mar;41(3):716-26
pubmed: 22903959
Am J Epidemiol. 2002 May 15;155(10):965-71
pubmed: 11994237
Respir Med. 1998 Nov;92(11):1281-8
pubmed: 9926141
Pediatrics. 2009 Mar;123 Suppl 3:S174-84
pubmed: 19221161
J Environ Public Health. 2010;2010:260525
pubmed: 20671946
Nicotine Tob Res. 2009 Jan;11(1):12-24
pubmed: 19246437
Eur Respir J. 2003 Sep;22(3):462-9
pubmed: 14516136